Name | NAcM-OPT |
---|
Description | NAcM-OPT is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor, which potently inhibits the DCN1-UBE2M interaction[1]. |
---|---|
Related Catalog | |
Target |
DCN1[1] |
In Vitro | NAcM-OPT (Compound 67) is orally bioavailable, well tolerated in mice, and currently used to study the effects of acute pharmacologic inhibition of the DCN1-UBE2M interaction on the NEDD8/CUL pathway[1]. |
References |
Molecular Formula | C23H29Cl2N3O |
---|---|
Molecular Weight | 434.40 |